Alpha-Globin Gene Sequencing, Blood
Use
Alpha-globin gene sequencing is instrumental in identifying both point alterations and small deletions within the alpha-globin genes that account for nondeletional alpha-thalassemia variants. While large deletions are common, representing 90% of alterations, this sequencing aids in detecting the remaining 10%. Alpha-thalassemia is globally prevalent, impacting approximately 5% of the population and is common among individuals from Southeast Asian, African, Mediterranean, Indian, and Middle Eastern descent. This sequencing is particularly useful as a follow-up to abnormal hemoglobin electrophoresis when alpha-globin chain variants are identified or in symptomatic individuals to test for nondeletional alpha thalassemia.
Special Instructions
This test is not orderable directly; it is available only as a reflex test and must be considered in conjunction with hemoglobin electrophoresis, clinical insights, family history, and other laboratory data.
Limitations
This assay will not detect large deletions or duplications within the alpha-globin genes. It should be interpreted with other clinical findings, and the accuracy depends on the information provided. Misinterpretation may result if the supplied information is incomplete. Rare genetic polymorphisms could contribute to false-negative or false-positive results, necessitating further testing if the findings are discordant with clinical observations.
Methodology
Sanger
Biomarkers
LOINC Codes
- 87730-8
- 50397-9
- 59466-3
Result Turnaround Time
10 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
4 mL
Minimum Volume
1 mL
Container
Lavender top (EDTA); Yellow top (ACD) acceptable
Causes for Rejection
Moderately to severely clotted
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 14 days |
